Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,200 across all filing types
Latest filing 2022-02-09 Regulatory Filings
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to stock exchanges regarding the reclassification of certain promoters from 'Promoter/Promoter Group' to 'Public' shareholding category under Regulation 31A of the SEBI Listing Regulations. It references previous intimations and approvals related to this reclassification. The content is focused on notifying regulatory bodies about changes in shareholding categories rather than reporting financial results, management changes, or other report types. The document length is 2563 characters, which is relatively short and primarily serves as a regulatory notification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-02-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a notification about an upcoming earnings call to discuss the un-audited financial results for the quarter and nine months ended December 31, 2021. It includes details about the date, time, dial-in information, and mentions that the transcript will be posted on the company's website. The document itself does not contain the financial results or the transcript, but is an announcement of the call event. Therefore, it is not the earnings release (ER) or the call transcript (CT) itself, but an announcement related to the call. Given the options, the best fit is Call Transcript (CT) because the document is about the earnings call event and the transcript will be posted later. However, since this document is only announcing the call and not the transcript itself, it is closest to a Call Transcript (CT) announcement. Confidence is high as the document clearly states it is about the earnings call for financial results discussion.
2022-02-09 English
Board Meeting — Fund Raising
Capital/Financing Update Classification · 100% confidence The document is a letter addressed to stock exchanges regarding a proposed fund raising by the company through issuance of equity shares or convertible warrants via preferential issue. It references a future Board Meeting to consider the proposal and mentions seeking shareholder approval through Postal Ballot or Extraordinary General Meeting. The document is an announcement of a financing activity and does not contain financial statements or detailed financial results. The length is short (1770 characters), and it is clearly an update on capital raising plans. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-02-07 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the issuance of duplicate share certificates due to loss of original certificates by shareholders. It references SEBI regulations and a SEBI circular about the procedural requirements for issuing duplicate certificates. The content is focused on informing the exchanges about shareholder requests and the company's compliance with regulatory requirements. There are no financial statements, earnings data, or management discussions present. The document is a regulatory announcement related to share certificate administration and compliance, not a financial report or meeting material. Given the nature and length of the document (3127 characters), it is best classified as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2022-02-03 English
Allotment of Securities
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement (1300 characters) addressed to stock exchanges regarding the allotment of shares under an employee stock option plan (ESOP). It details the number of shares allotted, the increase in paid-up share capital, and confirms that the new shares rank pari passu with existing shares. There is no financial statement or detailed financial analysis, only a notification of a capital change due to share allotment. This fits the definition of a Share Issue/Capital Change announcement rather than a full financial report or other filing types.
2022-01-28 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a short notice informing about the rescheduling of a Board Meeting originally planned to approve unaudited financial results for the quarter and nine months ended December 31, 2021. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, which pertains to board meeting disclosures. The document does not contain any financial data or results itself, nor does it include detailed financial analysis or reports. It is an announcement related to management activity, specifically about the scheduling of a board meeting. Therefore, it fits best under Board/Management Information (MANG). The document length is short (1497 characters), and it is not a report or a certification, so it is not RNS or RPA. Confidence is high given the clear context and content.
2022-01-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.